The following pages link to Mitogen-activated protein kinase kinase
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Chemotherapy (links | edit)
- G protein-coupled receptor (links | edit)
- Protein kinase (links | edit)
- Yersinia pestis (links | edit)
- Kinase (links | edit)
- Breast cancer (links | edit)
- Mek (links | edit)
- Protein kinase A (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- AMP-activated protein kinase (links | edit)
- Imatinib (links | edit)
- Trastuzumab (links | edit)
- Cyclin-dependent kinase (links | edit)
- ATC code L (links | edit)
- ATC code L01 (links | edit)
- Gefitinib (links | edit)
- GSK-3 (links | edit)
- Mitogen-activated protein kinase (links | edit)
- Protein kinase C (links | edit)
- Rituximab (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Mitogen (links | edit)
- Titin (links | edit)
- Protein kinase B (links | edit)
- Pyruvate dehydrogenase lipoamide kinase isozyme 1 (links | edit)
- CGMP-dependent protein kinase (links | edit)
- CAMK (links | edit)
- Phototropin (links | edit)
- T-cell receptor (links | edit)
- ATM serine/threonine kinase (links | edit)
- Aurora kinase (links | edit)
- Erlotinib (links | edit)
- Ibritumomab tiuxetan (links | edit)
- Neurofibromatosis type II (links | edit)
- MTOR (links | edit)
- Alemtuzumab (links | edit)
- Gemtuzumab ozogamicin (links | edit)
- Epithelial–mesenchymal transition (links | edit)
- Targeted therapy (links | edit)
- Sorafenib (links | edit)
- Scaffold protein (links | edit)
- IKBKAP (links | edit)
- MAP kinase kinase kinase (links | edit)
- Sunitinib (links | edit)
- IRAK4 (links | edit)
- Lapatinib (links | edit)
- Myosin light-chain kinase (links | edit)
- List of MeSH codes (D08) (links | edit)